Beijing Med-Pharm Announces Listing on the Over the Counter Bulletin Board.

PLYMOUTH MEETING, Pa. -- Beijing Med-Pharm Corporation (BJGP BJGP British Journal of General Practice .PK) today announced that its shares of common stock have been accepted for quotation on the over the counter bulletin board (the "OTCBB OTCBB

See OTC Bulletin Board (OTCBB). ") under the trading symbol Trading symbol

See: Ticker symbol "BJGP.OB." Trading will begin immediately.

"Gaining access to more prominent and efficient equity markets is an important component of our growth strategy," said Fred M. Powell, Chief Financial Officer of Beijing Med-Pharm.

The OTCBB is a regulated quotation service of the National Association of Securities Dealers National Association of Securities Dealers (NASD)

Nonprofit organization formed under the joint sponsorship of the investment bankers' conference and the SEC to comply with the Maloney Act, which provides for the regulation of the OTC market. that displays real-time quotes, last-sale prices, and volume information in over-the-counter ("OTC OTC

See: Over-the-counter.

OTC

See over-the-counter market (OTC). ") equity securities. An OTC equity security generally is any equity that is not listed or traded on NASDAQ NASDAQ
in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on or a national securities exchange. OTCBB securities, of which there are more than 3,300, include national, regional, and foreign equity issues, warrants, units, American Depositary Receipts, and Direct Participation Programs. Companies listed on the OTCBB are required to file current financial statements with the Securities and Exchange Commission or a banking or insurance regulator.

About Beijing Med-Pharm Corporation

Beijing Med-Pharm is a pharmaceutical marketing and distribution company that offers the following services in China: pre-market entry analysis; clinical trial management; product registration; market research; pharmaceutical distribution to hospitals; and pharmaceutical marketing to physicians, hospitals and other healthcare providers.

COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.

Reader Opinion

Article Details
Printer friendly Cite/link Email Feedback
Publication:	Business Wire
Date:	Feb 22, 2006
Words:	210
Previous Article:	Autoliv Promontory Facility Receives Shingo Prize for Excellence in Manufacturing.
Next Article:	European, Canadian and Asian Traders Begin Move to No- and Low-Touch Channels, Says TABB Group Analysis of Global Equity Trading from the Buy-Side's...

Related Articles
SMALL SACRIFICE?; NASDAQ LOOKS AT DROPPING 3,400 STOCKS FROM LISTINGS.
Beijing Med-Pharm Files S1 Registration Statement.
Beijing Med-Pharm Corp. Announces It's Intent to Acquire Majority Interest in Rongheng Corp. of Shanghai, People's Republic of China.
Beijing Med-Pharm Corporation Raises $6.3 Million in Private Placement.
Beijing Med-Pharm Corporation Notified by the People's Republic of China Ministry of Commerce That Acquisition of Beijing Wanwei Pharmaceutical Co.,...
Beijing Med-Pharm Corporation and pSivida Reach Agreement to Distribute BrachySil(TM) Throughout the People's Republic of China.
Beijing Med-Pharm Corporation Enters into Agreement Regarding Acquisition of Majority Interest in Shanghai Pharmaceutical Distributor.
Beijing Med-Pharm Corporation Expands Its Women's Health Portfolio in China Through Agreement with Taiwan Biotech Co., Ltd.
Beijing Med-Pharm Corporation to Trade on NASDAQ Capital Market.
Beijing Med-Pharm Corporation Signs Letter of Intent to Acquire Minority Interest in Sunstone Pharmaceutical Co., Ltd.